Redwood Wealth Management Group’s AbbVie ABBV Stock Holding History

Redwood Wealth Management Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$963K	Sell	4,427 -66	-1%	-$14.6K	0.42%	54
2025 Q4	$1.03M	Sell	4,493 -16	-0.4%	-$3.65K	0.43%	54
2025 Q3	$1.04M	Sell	4,509 -130	-3%	-$26.5K	0.44%	54
2025 Q2	$861K	Sell	4,639 -34	-0.7%	-$6.32K	0.39%	52
2025 Q1	$979K	Sell	4,673 -26	-0.6%	-$5.05K	0.5%	48
2024 Q4	$835K	Sell	4,699 -17	-0.4%	-$3.13K	0.41%	54
2024 Q3	$931K	Buy	4,716 +21	+0.4%	+$3.92K	0.46%	52
2024 Q2	$805K	Sell	4,695 -154	-3%	-$25.5K	0.61%	32
2024 Q1	$883K	Sell	4,849 -190	-4%	-$32.7K	0.94%	30
2023 Q4	$781K	Sell	5,039 -420	-8%	-$61.2K	0.87%	29
2023 Q3	$814K	Sell	5,459 -48	-0.9%	-$7.05K	0.95%	26
2023 Q2	$742K	Sell	5,507 -366	-6%	-$53.7K	0.82%	31
2023 Q1	$936K	Buy	5,873 +177	+3%	+$27.1K	1.06%	23
2022 Q4	$921K	Buy	+5,696	New	+$873K	1.15%	19

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Redwood Wealth Management Group's ABBV Position: Q1 2026 in Review

Redwood Wealth Management Group reduced its AbbVie (ABBV) stake by 1.5% in Q1 2026, selling an estimated $14.6K and leaving 4,427 shares worth $963K. The position accounts for 0.42% of the portfolio, ranked #54.

Redwood Wealth Management Group first reported a position in ABBV in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.04M in Q3 2025. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Redwood Wealth Management Group held 4,427 shares of AbbVie worth $963K as of Q1 2026.
Redwood Wealth Management Group sold 66 AbbVie shares in Q1 2026, an estimated $14.6K.
AbbVie made up 0.42% of Redwood Wealth Management Group's portfolio in Q1 2026, its #54 holding.
Redwood Wealth Management Group first reported a position in AbbVie in Q4 2022 and has held it in 14 quarters since.
Redwood Wealth Management Group's AbbVie position peaked at $1.04M in Q3 2025.
4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Redwood Wealth Management Group's 13F filing for Q1 2026, filed 24 Apr 2026.